Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Why Zero Based Budgeting Is Better Than Traditional Budgeting
This overview explains why Zero Based Budgeting often yields tighter control over spending than traditional methods, helping you align expenses with goals.
27,774 articlesWhy GlobalFoundries Stock Skyrocketed This Week: Insights
GlobalFoundries stock skyrocketed this week as quantum computing initiatives and government backing boosted optimism....
Stocks Long-Term Investors Should Buy in May: 2 Top Picks
May often stirs market chatter about seasonal weakness, yet patient investors can find lasting value. Here are two gr...
Hynix Joins Nasdaq: A Nasdaq-100 Stock to Watch 2026
SK hynix joins Nasdaq signals AI memory demand, but a Nasdaq-100 semiconductor stock could offer a stronger upside in...
This Spacex Catalyst Coming: Why Investors Are Buying Now
As August approaches, a key SpaceX catalyst coming could shift the balance for investors. This guide breaks down what...
Wall Street Scrapped 25-Year-Old PDT Rule: Is HOOD a Buy?
A long standing trading rule is gone, and it could change how millions of small investors trade. This shift may lift ...
What Know About This Exit: A $194M China Logistics Stock Move
A Hong Kong based fund recently exited its stake in a leading China logistics platform for about $194 million. This a...
Alphabet Anthropic's Partnership Could Boost AI Investing Today
A growing alliance between Alphabet and Anthropic could redefine how AI is trained and deployed. This piece breaks do...
Remitly Director's $522k Sale: Insider Moves and Insights
Insider moves can reveal clues about a company's near-term prospects. This article dives into the remitly director's ...
Biocryst (BCRX) 2026 Earnings: What Investors Should Know
BioCryst faces a pivotal year. This practical guide breaks down what biocryst (bcrx) 2026 earnings could mean for inv...
Advantage (ADV) 2025 Earnings Outlook and Strategies
Advantage (ADV) stunned some on the street with the Q2 2025 numbers, while others saw a path to steady growth. This d...
Capital Sold Victoria’s Secret: Is This Stock a Buy or Sell?
A notable stake change in Victoria’s Secret & Co. raises questions for investors. This article explains what the capi...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status